Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 34
Phase 42

Trial Status

Other7

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT00300560Phase 3PrincipalInvestigator

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

Infections
Unknown
NCT00917319Not ApplicablePrincipalInvestigator

Prevention and Control of Healthcare-Associated Infections

Nosocomial Infection
Unknown
NCT00920270Phase 3PrincipalInvestigator

Nebulized Colistin for Hospital-Acquired Pneumonia

Pneumonia
Unknown
NCT01297842Phase 4PrincipalInvestigator

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Drug Safety
Unknown
NCT01297894Phase 3PrincipalInvestigator

Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter Baumannii

Drug Safety
Unknown
NCT01342731Phase 4PrincipalInvestigator

Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii

Antibiotic Resistant Infection
Unknown
NCT01501968Phase 3PrincipalInvestigator

Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity

Drug Safety
Unknown

All 7 trials loaded